Latest stories
Featured
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development 12 February 2024
- Hikma launches Midazolam Injection, USP, in a prefilled syringe in the US Press Release, Corporate 08 May 2024 Hikma launches Midazolam Injection, USP, in a prefilled syringe in the US
- Bringing Better Health Within Reach: Hikma’s journey to become the Partner of choice in MENA Insight, Corporate 29 April 2024 Bringing Better Health Within Reach: Hikma’s journey to become the Partner of choice in MENA
- Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated Press Release, Financial Results 25 April 2024 Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated
- Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business Press Release, Corporate 15 April 2024 Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business
Related content